This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Zhirong Mo: Innovator in Pharmaceutical Composition
Introduction
Zhirong Mo is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on drug formulations. His expertise and dedication have led to advancements that benefit the medical community and patients alike.
Latest Patents
Zhirong Mo holds a patent for a pharmaceutical composition. This patent specifically relates to abiraterone acetate, where a 300 mg dose is bioequivalent to a 1000 mg dose of Zytiga® in healthy male subjects in a fasting state. This innovation has the potential to enhance treatment options for patients requiring this medication.
Career Highlights
Zhirong Mo is associated with Jiangsu Hengrui Pharmaceuticals Co., Ltd., a leading company in the pharmaceutical industry. His work at this organization has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development in drug formulations.
Collaborations
Zhirong Mo has worked alongside notable colleagues such as Caiyun Pan and Ailing Chen. Their combined efforts in the pharmaceutical field have fostered an environment of innovation and excellence.
Conclusion
Zhirong Mo's contributions to pharmaceutical compositions exemplify the impact of innovative thinking in medicine. His work not only advances drug formulations but also enhances patient care and treatment efficacy.